Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de Christian S. Schade
Leeftijd : 59
Vermogen : 3 482 047 USD
Belangrijkste bedrijven : Integra LifeSciences Holdings Corporation - Aprea Therapeutics, Inc.
Overzicht 
Christian S. Schade is a businessperson who has been at the head of 5 different companies and presently occupies the position of Chairman, President & Chief Executive Officer of Aprea Therapeutics, Inc. and President, Chief Executive Officer & Director at Aprea Therapeutics AB (a subsidiary of Aprea Therapeutics, Inc.). Mr. Schade is also on the board of Integra LifeSciences Holdings Corp. and Sapience Therapeutics, Inc. and Chairman at Princeton Academy of the Sacred Heart.

In the past he occupied the position of Chief Financial Officer & Executive Vice President of NRG Energy, Inc., Principal at JPMorgan Chase & Co., Chief Executive Officer & Director at Novira Therapeutics, Inc., Managing Director at Merrill Lynch International, Chief Financial Officer & Senior VP-Administration at Medarex, Inc. and Chief Financial Officer & Executive Vice President for Omthera Pharmaceuticals, Inc.

Christian S. Schade received an undergraduate degree from Princeton University and an MBA from The Wharton School of the University of Pennsylvania.


Posities en verantwoordelijkheden van Christian S. Schade 
NaamTitel Van
Integra LifeSciences Holdings Corporation
(Medische apparatuur, benodigdheden & distributie)
Independent Director 2006
Aprea Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Chairman, President & Chief Executive Officer 2020
Princeton Academy of the Sacred Heart Chairman 2009
Aprea Therapeutics AB President, Chief Executive Officer & Director 2016
Sapience Therapeutics, Inc. Director -


Belangnemingen van Christian S. Schade 
NaamAandelen%Totale waarde
Integra LifeSciences Holdings Corporation (IART)
(Medische apparatuur, benodigdheden & distributie)
45 6000,054%3 430 488 USD
Aprea Therapeutics, Inc. (APRE)
(Biotechnologie & Medisch Onderzoek)
11 1600,053%51 559 USD


Christian S. SchadePersoonlijk netwerk 
Meest gelezen nieuws 
22/09WILLIAM ACKMAN : Ackman's Pershing Square fonds stijgt bij beursdebuut Universal
MR
24/09CATHIE WOOD : Chinese maatregelen tegen bitcoin opnieuw een klap voor Cathie Woods ARK ETF
MR
15/09BRAD SMITH : Microsoft kondigt inkoop van eigen aandelen aan tot $60 mrd, verhoogt dividend
MR
14/09STEPHEN SCHERR : Goldman Sachs benoemt Coleman als nieuwe CFO, ter vervanging van Scherr
MR
15/09ILHAM KADRI : Activist Bluebell Capital wil ontslag CEO Solvay
AM
Meer nieuws


© 2021 People and Ownership :   
Christian S. Schade Verbindingen